Sponsor

Danish Research Centre for Magnetic Resonance

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Danish Research Centre for Magnetic Resonance appears in 17 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials17
Recruiting shown8
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

17 shown
A Comprehensive, Multimodal Characterization of Prodromal PD in Subjects With RBDNCT07790744 · lead sponsor · 2026-02-01
RECRUITING
prTMS as an Intervention for Bradykinesia in Parkinson's DiseaseNCT07397377 · lead sponsor · 2025-12-16
RECRUITING
Optimistic and Pessimistic Dopamine Signals in the Human Brain: a Mapping and Modelling Study in Health and Parkinson's DiseaseNCT07402928 · lead sponsor · 2025-06-02
RECRUITING
COpenhagen Magnetic Personalized Accelerated Brain Circuit Therapy for Treatment Resistant DepressionNCT06895863 · lead sponsor · 2025-01-15
RECRUITING
rTMS as an Intervention for Levodopa-induced DyskinesiaNCT06570824 · lead sponsor · 2024-08-22
RECRUITING
Fatigue Alleviation Through Neuromodulating Therapy in Multiple SclerosisNCT06569550 · lead sponsor · 2024-08-14
RECRUITING
Mapping Levodopa Effects on Cortico-basal Ganglia Circuit Function in Parkinson's DiseaseNCT06240624 · lead sponsor · 2022-08-15
ACTIVE_NOT_RECRUITING
Gray Matter Demyelination in Primary Progressive MS at 7TNCT04977622 · lead sponsor · 2021-11-30
UNKNOWN
Unravelling the Alteration of Brain Structure and Function in Parkinson´s Disease With Ultra-high Field MRINCT03866044 · lead sponsor · 2018-09-19
UNKNOWN
Cortical Lesions in Patients With Multiple SclerosisNCT03653585 · lead sponsor · 2018-09-04
COMPLETED
Investigating the Causal Role of preSMA in Levodopa-induced Dyskinesia in Parkinson's DiseaseNCT03354455 · lead sponsor · 2017-08-01
COMPLETED
Effect of Sleep Extension on Body Weight and Learning in Children (More2Sleep)NCT06341179 · collaborator · 2024-08-13
RECRUITING
Add-on MEmaNtine to Dopamine Modulation to Improve Negative Symptoms at First PsychosisNCT04789915 · collaborator · 2021-05-26
RECRUITING
The Metabolic Impact of Intermittent Carbohydrate Restriction in Individuals With Type 2 DiabetesNCT06144593 · collaborator · 2024-01-03
UNKNOWN
The Role of Dietary Carbohydrate and Fat Availability in the Regulation of Hepatic Lipid ContentNCT04581421 · collaborator · 2020-12-03
COMPLETED
Metabolic Adaptation to High-frequent Hypoglycaemia in Type 1 DiabetesNCT05095259 · collaborator · 2019-12-16
UNKNOWN
The Effects of Erythropoietin on Clinical Disability and Brain Pathology in Patients With Progressive Multiple SclerosisNCT01144117 · collaborator · 2009-11-01
UNKNOWN

Drugs studied in this sponsor's trials

6 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Danish Research Centre for Magnetic Resonance as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.
epinephrine1
epoetin alfa1
glucagon1
insulin, regular, human1
memantine1
placebo1

Sponsor roles

lead sponsor11
collaborator6
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.